U.S. Hematology Analyzers Market forecast to reach $4.27 billion and Europe $3.27 billion by 2035 as 5-part differential analyzers, digital morphology, point-of-care testing, and high-throughput laboratory automation gain adoption.

Austin, United States, Aug. 28, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, the global Hematology Analyzers Market Size was valued at USD 6.24 billion in 2025 and is projected to reach USD 11.63 billion by 2035, expanding at a CAGR of 6.42% from 2026 to 2035. Growth in the market is driven by higher numbers of tests being carried out, higher prevalence of anemia, leukemia, and other hematologic diseases, and the ongoing substitution of traditional blood analysis systems with hematology analyzers.

Laboratories are increasingly using 5- and 6-part differentials, AI-driven digital morphology systems, hematology at the point of care systems, and high throughput automation. This allows laboratories to better classify blood cells, minimize manual slide examination, speed up complete blood counts analysis, and handle higher numbers of samples.


Download the Hematology Analyzers Market Sample Report: https://www.snsinsider.com/sample-request/5665

Key Market Highlights

  • Market size, 2025: USD 6.24 Billion
  • Market forecast, 2035: USD 11.63 Billion
  • CAGR: 6.42% from 2026 to 2035
  • Largest region: North America
  • Fastest-growing region: Asia Pacific
  • Largest product type: Reagents & Consumables, 48.23% share in 2025
  • Fastest-growing product type: Instruments/Analyzers
  • Largest analyzer type: 5-Part Differential, approximately 44% share in 2025
  • Fastest-growing analyzer type: 6-Part Differential
  • Largest technology: Electrical Impedance, approximately 38% share in 2025
  • Fastest-growing technology: Flow Cytometry/Fluorescence
  • Largest application: Anemia, approximately 34% share in 2025
  • Fastest-growing application: Blood Cancer & Hematological Malignancies
  • Largest end user: Hospitals & Hospital Laboratories, approximately 52% share in 2025
  • Fastest-growing end user: Clinical & Diagnostic Laboratories

Hematology Analyzers Market Overview

Hematology analyzers are important diagnostic devices that help perform complete blood counts, differential cell counts, counting of cells, and morphological assessment of blood cells. This category includes the diagnostic tools required to diagnose and monitor anemia, infections, leukemia, lymphoma, myeloma, inflammation, and other diseases of the hematological system.

The demand is growing as hospitals and laboratories are increasingly moving towards automated testing environments and producing fast, standardized results. In addition, reagents and consumables are sources of recurring income, as any hematology analyzer requires constant use of diluents, lysing reagents, stains, controls, and calibration materials.

Artificial intelligence-based digital morphology systems have become an important part of modern laboratory operations. These platforms help classify blood cells automatically and prioritize samples that need further analysis. In addition, high-throughput hematology systems have gained importance as high-volume hospitals and reference laboratories are being created.

Strategic Market Outlook

Key growth areas are expected in point-of-care hematology, artificial intelligence-enabled digital morphology, 6-part differential testing, advancements in fluorescence technology, and laboratory automation solutions.

The relevance of point-of-care systems is increasing in emergency rooms, intensive care units, small-scale medical centers and remote locations, where fast CBC test results will help make quick decisions. On the other hand, new advanced analyzers are being incorporated with digital morphology and LIS solutions to build a connected hematology workflow solution.

However, high capital expenses on sophisticated equipment and the scarcity of skilled laboratory professionals are the key restraining factors, particularly in developing economies. The advanced 5-part and 6-part systems require skilled manpower for quality assurance and instrument management.

Hematology Analyzers Market Regional Analysis

North America remained the leading regional market in 2025. The United States accounted for approximately 87.4% of North American revenue, supported by advanced diagnostic infrastructure, high healthcare expenditure, strong blood disorder testing volumes, and the commercial presence of major hematology analyzer manufacturers.

The U.S. Hematology Analyzers Market was valued at approximately USD 2.29 billion in 2025 and is expected to reach approximately USD 4.27 billion by 2035, growing at a CAGR of approximately 6.44%.

The Europe Hematology Analyzers Market was valued at approximately USD 1.81 billion in 2025 and is projected to reach approximately USD 3.27 billion by 2035, expanding at a CAGR of approximately 6.10%. Germany accounted for approximately 22.3% of European revenue in 2025, while the United Kingdom, France, and Italy also represent important markets.

The Asia Pacific region represents the fastest-growing regional market. In 2025, China will represent about 44.8% of the total revenue generated in the Asia Pacific region, backed by growing investments in hospitals, health care facilities, and automated blood testing solutions.

Saudi Arabia accounted for approximately 31.2% of Middle East & Africa revenue in 2025, while Brazil represented approximately 44.2% of Latin America revenue.

Buy the Hematology Analyzers Market Report with Competitive Analysis and 2035 Forecast: https://www.snsinsider.com/checkout/5665

Hematology Analyzers Market Segment Analysis

By Product Type, Reagents & Consumables dominated the market with 48.23% share in 2025 due to recurring usage across installed analyzer systems. Instruments/Analyzers are the fastest-growing category as laboratories replace older equipment and expand automation.

By Analyzer Type, 5-Part Differential analyzers held approximately 44% market share in 2025. 6-Part Differential analyzers are the fastest-growing segment as additional measurements improve assessment of complex blood conditions.

By Technology, Electrical Impedance accounted for approximately 38% of the market in 2025. Flow Cytometry/Fluorescence is the fastest-growing technology owing to the high demand for more detailed cellular analysis.

By Application, Anemia held approximately 34% market share in 2025. Blood Cancer & Hematological Malignancies are the fastest-growing application segment, due to the increasing number of testings for leukemia, lymphoma, myeloma, and treatment monitoring.

By End User, Hospitals & Hospital Laboratories accounted for approximately 52% of revenue in 2025. Clinical & Diagnostic Laboratories are the fastest-growing end-user segment, owing to laboratory consolidation and demand for high-throughput automated testing.

Competitive Landscape

The Hematology Analyzers Market includes global diagnostics companies and specialized laboratory equipment manufacturers competing across analyzer performance, throughput, automation, reagent portfolios, digital morphology, and point-of-care applications.

Major companies include Sysmex Corporation, Abbott Laboratories, Beckman Coulter Inc. (Danaher), Siemens Healthineers, Mindray Medical International, HORIBA Ltd., Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, EKF Diagnostics, Boule Diagnostics AB, Diatron, Ortho Clinical Diagnostics, Transasia Bio-Medicals, Trivitron Healthcare, Agappe Diagnostics, Drew Scientific, and Erba Mannheim.

The competitive environment is increasingly focused on integrated platforms that combine analyzer hardware, recurring reagents, workflow automation, data connectivity, digital morphology, and advanced differential capabilities.

Explore the Complete Hematology Analyzers Market Report: https://www.snsinsider.com/reports/hematology-analyzers-market-5665

CONTACT: About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315-961-9094 (US)
Email: info@snsinsider.com